Our Sustainability Strategy and Governance

Strategy

Lilly unites caring with discovery to create medicines that make life better for people around the world. For nearly 150 years, we’ve developed and delivered trusted medicines that help people get better, feel better and live better. We remain committed to continuous progress and improving our positive impact on people, the planet and society.

Our sustainability strategy and efforts directly support Lilly’s purpose to discover and develop medicines that make life better. We are striving to:

Expand access to medications globally
Improve healthcare for individuals in resource-limited settings
Strengthen communities globally, including where we live and work
Foster a workforce that leverages various perspectives to innovate and deliver medicines
Minimize our environmental impact across the lifecycle of our products and our supply chains
Operate ethically and responsibly, guided by our core values of integrity, excellence and respect for people.

Governance

Our CEO and Board are actively engaged in strategic sustainability matters at Lilly. We also involve global employees in sustainability efforts for individual and collective impact.

Learn more about our sustainability corporate governance.

Goals

Our sustainability goals are embedded within our business strategy and operations. We establish ambitious, quantifiable targets and communicate our progress through this report and other stakeholder communications.

Explore Our Sustainability Goals

Lilly’s Sustainability Topics

Environmental	Social	Governance
Climate	Social: U.S. Access & Affordability	Governance: Business Ethics
Water	Social: Global Access & Health	Governance: Corporate Governance
Waste	Social: Community Engagement	Governance: Supply Chain Management
Product Stewardship	Social: Inclusion	Governance:
Biodiversity	Social: Employee Experience	Governance:
	Social: Patient Safety	Governance:
	Social: Human Rights	Governance:

Stakeholder Engagement and Topic Identification

Lilly has solicited input from internal and external people and organizations to better determine the sustainability issues that matter most to our company and stakeholders. We obtained input and prioritization from:

In addition to engaging with stakeholders, we frequently conduct peer benchmarking and integrate industry and sustainability trends, leveraging relevant sustainability reporting frameworks, including the Sustainability Accounting Standards Board (SASB) and Task Force on Climate-related Financial Disclosures (TCFD).

Through this process, we have focused on the 15 sustainability topics noted above, which represent important issues to internal and external stakeholders and are key to our company’s long-term success. These topics are aligned with the SASB standards for the Biotechnology and Pharmaceutical industry, and environmental issues addressed by TCFD. Our sustainability strategy is dynamic, and we review these priorities periodically to align our approach with topics relevant for Lilly, our stakeholders and our industry.

See important information about our Sustainability report.